REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,204,704 | -11.8% | 12,400 | -23.0% | 0.02% | -19.0% |
| Q2 2023 | $11,568,494 | +38.0% | 16,100 | +57.8% | 0.02% | +40.0% |
| Q1 2023 | $8,381,034 | +384.0% | 10,200 | +325.0% | 0.02% | +400.0% |
| Q4 2022 | $1,731,576 | +1154.8% | 2,400 | +1100.0% | 0.00% | – |
| Q3 2022 | $138,000 | -61.1% | 200 | -66.7% | 0.00% | – |
| Q2 2022 | $355,000 | -49.1% | 600 | -40.0% | 0.00% | -100.0% |
| Q1 2022 | $698,000 | +84.2% | 1,000 | +66.7% | 0.00% | – |
| Q4 2021 | $379,000 | -81.0% | 600 | -81.8% | 0.00% | -100.0% |
| Q3 2021 | $1,997,000 | +297.0% | 3,300 | +266.7% | 0.00% | – |
| Q2 2021 | $503,000 | -92.7% | 900 | -91.9% | 0.00% | -100.0% |
| Q2 2020 | $6,923,000 | +245.8% | 11,100 | +170.7% | 0.01% | +166.7% |
| Q1 2020 | $2,002,000 | -18.0% | 4,100 | -36.9% | 0.00% | +50.0% |
| Q4 2019 | $2,441,000 | +109.5% | 6,500 | +54.8% | 0.00% | +100.0% |
| Q3 2019 | $1,165,000 | +366.0% | 4,200 | +425.0% | 0.00% | – |
| Q2 2019 | $250,000 | -32.4% | 800 | -11.1% | 0.00% | – |
| Q1 2019 | $370,000 | -67.3% | 900 | -67.9% | 0.00% | -100.0% |
| Q3 2018 | $1,131,000 | +26.1% | 2,800 | +7.7% | 0.00% | 0.0% |
| Q2 2018 | $897,000 | +18.3% | 2,600 | +18.2% | 0.00% | 0.0% |
| Q1 2018 | $758,000 | -84.6% | 2,200 | -83.2% | 0.00% | -75.0% |
| Q4 2017 | $4,925,000 | +0.1% | 13,100 | +19.1% | 0.00% | 0.0% |
| Q3 2017 | $4,918,000 | +66.9% | 11,000 | +83.3% | 0.00% | +33.3% |
| Q2 2017 | $2,947,000 | -33.3% | 6,000 | -47.4% | 0.00% | -25.0% |
| Q1 2017 | $4,418,000 | +6.5% | 11,400 | +0.9% | 0.00% | 0.0% |
| Q4 2016 | $4,148,000 | +49.5% | 11,300 | +63.8% | 0.00% | +33.3% |
| Q3 2016 | $2,774,000 | -25.1% | 6,900 | -34.9% | 0.00% | -25.0% |
| Q2 2016 | $3,702,000 | +58.0% | 10,600 | +63.1% | 0.00% | +33.3% |
| Q1 2016 | $2,343,000 | -6.2% | 6,500 | +41.3% | 0.00% | 0.0% |
| Q4 2015 | $2,497,000 | +666.0% | 4,600 | +557.1% | 0.00% | – |
| Q3 2015 | $326,000 | -8.7% | 700 | 0.0% | 0.00% | – |
| Q2 2015 | $357,000 | +13.0% | 700 | 0.0% | 0.00% | – |
| Q1 2015 | $316,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 63,800 | $43,950,000 | 0.09% |
| Maven Securities LTD | 2,100 | $1,447,000 | 0.03% |
| JANE STREET GROUP, LLC | 71,400 | $49,185,000 | 0.02% |
| SIMPLEX TRADING, LLC | 26,600 | $18,323,000 | 0.02% |
| IMC-Chicago, LLC | 21,100 | $14,535,000 | 0.02% |
| Allianz Asset Management GmbH | 200 | $138,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 500 | $344,000 | 0.00% |